FDA and USP Workshop on Standards for Pharmaceutical Products-Critical Importance of Excipients in Product Development – Why Excipients are Important Now and In the Future

February 27-28, 2017

Rockville, MD

A discussion of how the quality and variability of excipients currently impact medicines and how they are expected to impact new technologies such as Continuous Manufacturing and Novel Delivery systems.

After this workshop, participants will be able to:

  • Develop strategy on excipients selection for complex drug products
  • Understand FDA’s position on Q1/Q2/Q3 in terms of risk assessment for product quality and clinical performance
  • Recognize and understand importance of excipient selection suitable to the drug product and process

Who Should Participate:
Both brand and generic drug industries as well as excipient makers and suppliers, formulators, regulators, analytical chemists, manufacturers and clinical pharmacologists, toxicologists, project management staff.

Please visit USP’s websitedisclaimer icon to register to attend the workshop.


Pallavi Nithyanandan

Page Last Updated: 01/25/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English